What are the signs and symptoms of phenytoin (Dilantin) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Phenytoin overdose is characterized by dose-related adverse effects, including ataxia, nystagmus, tremor, and somnolence, which can progress to more severe symptoms such as confusion, lethargy, and coma. The signs and symptoms of phenytoin overdose can be attributed to its neurological, cardiovascular, and metabolic effects. Early signs of overdose include nystagmus, ataxia, slurred speech, and drowsiness 1. As toxicity progresses, patients may develop confusion, lethargy, and potentially coma.

Some of the key symptoms associated with phenytoin overdose include:

  • Nystagmus (involuntary eye movement)
  • Ataxia (poor coordination)
  • Tremor
  • Somnolence (drowsiness)
  • Confusion
  • Lethargy
  • Coma
  • Cardiovascular symptoms such as hypotension, bradycardia, and cardiac arrhythmias are also possible 1.

It is essential to note that phenytoin toxicity often correlates with serum levels above 20 mcg/mL, with severe symptoms typically appearing above 30-40 mcg/mL. The drug's nonlinear pharmacokinetics mean small dose increases can cause disproportionately large increases in blood levels. Treatment involves discontinuing the medication, supportive care, and possibly activated charcoal for recent ingestions. Healthcare providers should monitor phenytoin levels in patients on this medication, especially when adjusting doses or adding interacting medications, to prevent toxicity 1.

From the FDA Drug Label

The most common manifestations encountered with phenytoin therapy are referable to this system and are usually dose-related. These include nystagmus, ataxia, slurred speech, decreased coordination, and mental confusion Dizziness, insomnia, transient nervousness, motor twitchings, paresthesias, somnolence and headaches have also been observed. Serum levels of phenytoin sustained above the optimal range may produce confusional states referred to as "delirium," "psychosis," or "encephalopathy," or rarely irreversible cerebellar dysfunction.

The signs and symptoms of phenytoin overdose include:

  • Nystagmus
  • Ataxia
  • Slurred speech
  • Decreased coordination
  • Mental confusion
  • Dizziness
  • Insomnia
  • Transient nervousness
  • Motor twitchings
  • Paresthesias
  • Somnolence
  • Headaches
  • Confusional states (delirium, psychosis, or encephalopathy)
  • Irreversible cerebellar dysfunction 2 2

From the Research

Signs and Symptoms of Phenytoin Overdose

The signs and symptoms of phenytoin (Dilantin) overdose include:

  • Nausea
  • Central nervous system dysfunction, such as:
    • Confusion
    • Nystagmus
    • Ataxia
  • Depressed conscious state
  • Coma
  • Seizures (in more severe cases)
  • Cardiac complications, such as:
    • Arrhythmias
    • Hypotension (rare, but may occur with parenteral administration of phenytoin or fosphenytoin) 3
  • Ataxia, giddiness, and vomiting have also been reported in cases of phenytoin overdose 4
  • Other symptoms, such as agitation, abnormal gait, and hallucinations, have been observed in patients with phenytoin toxicity 5

Treatment and Management

Treatment for phenytoin overdose is primarily supportive care, including:

  • Attention to vital functions
  • Management of nausea and vomiting
  • Prevention of injuries due to confusion and ataxia
  • Activated charcoal may be considered if the patient presents early, but its effectiveness is controversial 3
  • Hemodialysis and hemoperfusion may be used in severe cases, particularly with intravenous overdose 6
  • Plasmaphoresis has been used in some cases, but its effectiveness is not well established 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Phenytoin poisoning.

Neurocritical care, 2005

Research

The Phenytoin Ataxia Enigma Unveiled "A Case Report''.

Journal of pharmacy practice, 2025

Research

Treatment of severe intravenous phenytoin overdose with hemodialysis and hemoperfusion.

Medical science monitor : international medical journal of experimental and clinical research, 2008

Research

Adjunctive therapy of phenytoin overdose--a case report using plasmaphoresis.

Journal of toxicology. Clinical toxicology, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.